Gistar study

12/05/2026

08/05/2026

08/05/2026

Slimību profilakses un kontroles centrs ir pilnveidojis pieeju valsts organizēto vēža skrīninga programmu novērtēšanai un uzraudzībai, adaptējot indikatoru metodoloģiju atbilstoši pieejamajiem datiem un datu sistēmu attīstībai Latvijā.

Pieeja saskan ar EUCanScreen projekta mērķiem uzlabot vēža skrīninga programmu monitoringu un novērtēšanu Eiropas līmenī.

📊 The Centre for Disease Prevention and Control of Latvia (CDPC) Slimību profilakses un kontroles centrs has refined its approach to monitoring and evaluating nationally organised cancer screening programmes by adapting the indicator methodology to better reflect available data and ongoing developments in data systems.
The indicators cover cervical, breast, and colorectal cancer screening programmes and provide structured information on:
📩 invitation and examination coverage,
📈 participation rates,
🧪 distribution of primary screening test results.
The methodological refinement is based on European Commission quality assurance guidelines and internationally recognised recommendations, while also being adapted to the Latvian data environment and its evolving data quality framework.

🔗 Read more: https://www.spkc.gov.lv/lv/jaunums/latvija-uzlabota-veza-skrininga-programmu-novertesana-pilnveidojot-indikatoru-metodologiju-un-datu-vizualizacijas

08/05/2026

TOGAS projekta noslēguma konsorcija sanāksme

📢 11. maijā, Latvijas Universitāte Akadēmiskajā centrā "Zinātņu māja" (Jelgavas iela 3, Rīga) notiks TOGAS EU project (Towards Gastric Cancer Screening Implementation in the European Union) projekta noslēguma konsorcija sanāksme.

Pasākumu būs iespējams vērot arī tiešsaistē: https://teams.microsoft.com/meet/384803289165706?p=0W3aFhQXCwGAq2XG2S

Dienas kārtībā TOGAS pētījuma rezultāti par kuņģa vēža skrīninga ieviešanas iespējām 🇪🇺 Eiropas Savienībā:

🔬 Pilotpētījumi - trīs pētījumu rezultāti par H. pylori skrīningu un ārstēšanu, kombinēto augšējo un apakšējo kuņģa-zarnu trakta vēža skrīningu, kā arī H. pylori izskaušanas ilgtermiņa iedarbību.

📊 Sabiedrības un politikas veidotāju viedokļi - iedzīvotāju aptaujas, dalībvalstu aptaujas un fokusgrupu rezultāti.

💰 Izmaksu efektivitāte - kuņģa vēža profilakses ekonomiskais modelējums.

📋 Projekta administratīvais noslēgums - gala ziņojuma sagatavošana un finansiālais pārskats.

🔭 Nākotnes perspektīvas - iepazīšanās ar TOGAS Plus projektu, kas turpinās uzsākto darbu.

Sanāksmē piedalās projekta konsorcija locekļi, Eiropas Veselības un digitālās izpildaģentūras (HaDEA) un DG SANTE pārstāvji, kā arī Ārējās konsultatīvās padomes eksperti.

06/05/2026

Tuvojoties svētkiem, īpaši svarīgi ir atcerēties par palīdzību citiem ❤️
Šobrīd īpaši nepieciešamas O- un B- asins grupas asinis!
Pirmssvētku laikā donoru aktivitāte bieži samazinās, bet nepieciešamība slimnīcās nepazūd. Tieši tagad Tava palīdzība ir īpaši nozīmīga 🙏
Iepazīsties ar donoru pieņemšanas laikiem:
https://www.vadc.lv/donoriem/izbraukumi-un-ziedosanas-vietas
Nāc un izdari labu darbu – tas aizņem tikai brīdi, bet kādam nozīmē visu ❤️

04/05/2026

Sveicam Latvijas Republikas Neatkarības atjaunošanas dienā! Būsim lepni par savu valsti un cilvēkiem, ar pašaizliedzību kalposim Tēvzemei un Zinātnei!

Priecīgus svētkus! 💙

30/04/2026

Gastric cancer remains a significant health burden across Europe. Yet, a new publication highlights an important shift: prevention is gaining momentum, supported by a growing number of coordinated European initiatives.

The article provides a comprehensive overview of key efforts, including:
▪️ Population-based Helicobacter pylori screen-and-treat strategies (e.g. GISTAR, EUROHELICAN, TOGAS)
▪️ Integration of gastric cancer prevention within colorectal cancer screening programmes
▪️ Real-world data collection through initiatives such as Hp-EuReg
▪️ Emerging EU-level actions, including the development of European guidelines and the inclusion of H. pylori management in the latest European Code Against Cancer

Importantly, these initiatives are not only generating clinical evidence, but also addressing feasibility, cost-effectiveness, and acceptability, key elements for successful implementation at population level.

The full study is available here: https://onlinelibrary.wiley.com/doi/10.1111/hel.70126




Latvijas Universitāte Erasmus MC Digestive Cancers Europe - for Patients European Cancer Organisation EU Science Hub - Joint Research Centre

30/04/2026

📢 New global guidance on gastric cancer prevention!

An IARC Working Group has released new recommendations on how to implement population-based Helicobacter pylori “screen-and-treat” strategies to help prevent gastric cancer. Still one of the leading causes of cancer death worldwide.

The guidance is accompanied by a publication in The New England Journal of Medicine and was led by Dr Jin Young Park (IARC), Head of the Gastric Cancer Prevention Team at IARC.

While this is not a TOGAS output, we’re proud that many experts involved in TOGAS contributed to this Working Group, reinforcing the strong scientific alignment between global evidence and TOGAS’s mission to support prevention and early detection strategies in Europe.👏

🔗 IARC announcement: https://www.iarc.who.int/news-events/iarc-working-group-report-on-helicobacter-pylori-screen-and-treat-strategies-for-gastric-cancer-prevention/
🔗 NEJM article: https://www.nejm.org/doi/10.1056/NEJMsb2515372




Latvijas Universitāte CHU de Nantes Erasmus MC Digestive Cancers Europe - for Patients European Cancer Organisation Otto-von-Guericke-Universität Magdeburg European Commission EU Science Hub - Joint Research Centre

30/04/2026

PERIFORMANCE Open Call – From Idea to Submission: Final Guidance for Applicants
Is your organisation active in cancer research or care? Don’t miss the chance to secure up to €10,000 to fund your stakeholder engagement initiatives!

Join our practical webinar on the PERIFORMANCE Open Call and learn how to finalise your application for local or regional activities. We will provide all the guidance you need to submit a strong proposal before the deadline.

What to expect:
Eligibility criteria and eligible activities.
Step-by-step guide to the application form.
Practical tips and live Q&A.

🗓 Date: 7 May 2026 🕒 Time: 15:00 CEST
📍 Registration: https://cesnet.zoom.us/webinar/register/WN__ZO-ChXCTKKyQbjzslVZGw #/registration
ℹ️ More info: periformance.eu/open-call/

30/04/2026

🧫 Did you know why antibiotic resistance matters for H. pylori prevention?

Treating Helicobacter pylori can help prevent gastric cancer, but it only works when treatment works.

Across Europe, antibiotic resistance is making some H. pylori therapies less effective. That’s why prevention strategies need more than a “standard recipe”: they require monitoring resistance patterns, choosing the right regimens, and supporting adherence so people can complete treatment safely.

🔊TOGAS supports building the evidence for effective, practical gastric cancer prevention approaches. So future screening and prevention strategies can be designed to work in real health systems.




Latvijas Universitāte Erasmus MC Digestive Cancers Europe - for Patients European Commission EU Science & Innovation